|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Blood Disease | |||||
| Cerebrovascular Accident | |||||
| Anemia, Sickle Cell | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Anemia | |||||
| Cerebral Infarction | |||||
| Hematologic Diseases | |||||
| Stroke | |||||
| 3 | More general conditions related to this trial | ||||
| Anemia, Hemolytic | |||||
| Anemia, Hemolytic, Congenital | |||||
| Brain Diseases | |||||
| Brain Infarction | |||||
| Brain Ischemia | |||||
| Cardiovascular Diseases | |||||
| Central Nervous System Diseases | |||||
| Cerebrovascular Disorders | |||||
| Genetic Diseases, Inborn | |||||
| Hemoglobinopathies | |||||
| Nervous System Diseases | |||||
| Vascular Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Blood Transfusion | |||||
| 5 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||